1.Chan BK, Estrada AA, Chen H, Atherall J, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Dominguez SL, Drummond J, Gill A, Kleinheinz T, Le Pichon CE, Medhurst AD, Liu X, Moffat JG, Nash K, Scearce-Levie K, Sheng Z, Shore DG, Van de Poël H, Zhang S, Zhu H, Sweeney ZK.. (2013) Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor., 4 (1):[PMID:24900567][10.1021/ml3003007]
2.Estrada AA, Chan BK, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chen H, Dominguez SL, Dotson J, Drummond J, Flagella M, Fuji R, Gill A, Halladay J, Harris SF, Heffron TP, Kleinheinz T, Lee DW, Le Pichon CE, Liu X, Lyssikatos JP, Medhurst AD, Moffat JG, Nash K, Scearce-Levie K, Sheng Z, Shore DG, Wong S, Zhang S, Zhang X, Zhu H, Sweeney ZK.. (2014) Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors., 57 (3):[PMID:24354345][10.1021/jm401654j]
3.Gancia E, De Groot M, Burton B, Clark DE.. (2017) Discovery of LRRK2 inhibitors by using an ensemble of virtual screening methods., 27 (11):[PMID:28408230][10.1016/j.bmcl.2017.03.098]
